Published in Transpl Int on May 16, 2011
Graft and patient survival outcomes of a third kidney transplant. Transplantation (2015) 1.41
Risk-adjusted analysis of relevant outcome drivers for patients after more than two kidney transplants. J Transplant (2015) 0.78
Patterns of Early Rejection in Renal Retransplantation: A Single-Center Experience. J Immunol Res (2016) 0.75
Immunologic and non-immunologic complications of a third kidney transplantation. Korean J Intern Med (2015) 0.75
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat Protoc (2008) 3.47
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res (2009) 2.75
Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation (2009) 2.28
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res (2006) 2.26
Biliary reconstruction using a side-to-side choledochocholedochostomy with or without T-tube in deceased donor liver transplantation: a prospective randomized trial. Ann Surg (2009) 2.19
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl (2003) 2.04
Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2007) 2.00
Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept. Transpl Int (2010) 1.99
Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival. World J Surg (2014) 1.98
The faster the better: anastomosis time influences patient survival after deceased donor kidney transplantation. Transpl Int (2015) 1.95
Hybrid video-assisted thoracic surgery-robotic minimally invasive right upper lobe sleeve lobectomy. Ann Thorac Surg (2011) 1.80
Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med (2010) 1.80
Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet (2004) 1.80
Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. Transpl Int (2009) 1.77
Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg (2008) 1.74
Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg (2006) 1.66
Immunohistochemical detection of hypoxia-inducible factor-1alpha in human renal allograft biopsies. J Am Soc Nephrol (2006) 1.61
Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transpl (2006) 1.60
The International Registry on Hand and Composite Tissue Transplantation. Transplantation (2010) 1.59
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Nephrol Dial Transplant (2005) 1.50
Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell (2008) 1.49
Nighttime procedures are not associated with adverse outcomes in kidney transplantation. Transpl Int (2013) 1.49
Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. Transplantation (2002) 1.48
Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome. Liver Transpl (2008) 1.47
Proteomic profiling of acute cardiac allograft rejection. Transplantation (2009) 1.44
Estradiol enhances murine cardiac allograft rejection under cyclosporin and can be antagonized by the antiestrogen tamoxifen. Transplantation (2002) 1.44
Growth Hormone Therapy Accelerates Axonal Regeneration, Promotes Motor Reinnervation, and Reduces Muscle Atrophy following Peripheral Nerve Injury. Plast Reconstr Surg (2016) 1.43
Tetrahydrobiopterin protects the kidney from ischemia-reperfusion injury. Kidney Int (2010) 1.41
Enteroscopic biopsies in the management of pancreas transplants: a proof of concept study for a novel monitoring tool. Transplantation (2012) 1.40
Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation (2005) 1.39
Preparing for prospective clinical trials: a national initiative of an excellence registry for consecutive pancreatic cancer resections. World J Surg (2014) 1.39
Single shot of alemtuzumab as induction therapy after kidney transplantation is sufficient. Transpl Int (2011) 1.39
The vascular nature of hemorrhoids. J Gastrointest Surg (2006) 1.38
Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection. Transplantation (2003) 1.35
The international registry on hand and composite tissue transplantation. Transplantation (2008) 1.35
Identification of the gene encoding alkylglycerol monooxygenase defines a third class of tetrahydrobiopterin-dependent enzymes. Proc Natl Acad Sci U S A (2010) 1.33
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol (2009) 1.31
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Second report (1998-2006) of the International Registry of Hand and Composite Tissue Transplantation. Transpl Immunol (2007) 1.29
Neopterin, a prognostic marker in human malignancies. Cancer Lett (2009) 1.28
Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int J Cancer (2011) 1.28
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol (2004) 1.26
Anesthetic management in upper extremity transplantation: the Pittsburgh experience. Anesth Analg (2012) 1.25
Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxid Redox Signal (2007) 1.24
Age and immune response in organ transplantation. Transplantation (2005) 1.23
Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochim Biophys Acta (2011) 1.22
Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J Exp Med (2013) 1.22
Heterogeneity of mitochondria and mitochondrial function within cells as another level of mitochondrial complexity. Int J Mol Sci (2009) 1.22
Real-time three-dimensional Fourier-domain optical coherence tomography video image guided microsurgeries. J Biomed Opt (2012) 1.21
Possible role of cytoskeleton in intracellular arrangement and regulation of mitochondria. Exp Physiol (2003) 1.19
Complete hepatic ischemia due to torsion of a large accessory liver lobe: first case to require transplantation. Transpl Int (2005) 1.19
Mitochondrial defects and heterogeneous cytochrome c release after cardiac cold ischemia and reperfusion. Am J Physiol Heart Circ Physiol (2003) 1.18
Evaluation of mitochondrial respiratory function in small biopsies of liver. Anal Biochem (2002) 1.17
Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact? Anticancer Res (2004) 1.16
Revised morphology and hemodynamics of the anorectal vascular plexus: impact on the course of hemorrhoidal disease. Int J Colorectal Dis (2008) 1.15
14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Clin Cancer Res (2005) 1.15
Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Transplantation (2006) 1.12
Early experience with robot-assisted surgery for mediastinal masses. Ann Thorac Surg (2004) 1.11
Subcellular heterogeneity of mitochondrial function and dysfunction: evidence obtained by confocal imaging. Mol Cell Biochem (2004) 1.11
Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle (2007) 1.11
Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients. Am J Transplant (2005) 1.11
The cell-type specificity of mitochondrial dynamics. Int J Biochem Cell Biol (2009) 1.11
Management of esophageal perforations. Surg Endosc (2010) 1.10
High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Transpl Immunol (2008) 1.10
Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege. J Immunol (2007) 1.08
Mitochondrial subpopulations and heterogeneity revealed by confocal imaging: possible physiological role? Biochim Biophys Acta (2006) 1.08
Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation (2004) 1.07
Results and complications after Swedish adjustable gastric banding-10 years experience. Obes Surg (2009) 1.07
Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue. Cancer Lett (2006) 1.07
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06
Symptomatic lymphoceles after kidney transplantation - multivariate analysis of risk factors and outcome after laparoscopic fenestration. Clin Transplant (2009) 1.06
Extended surgical resection for xanthogranulomatous cholecystitis mimicking advanced gallbladder carcinoma: A case report and review of literature. World J Gastroenterol (2006) 1.05
Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation (2002) 1.05
Fatal endocarditis due to extended spectrum betalactamase producing Klebsiella terrigena in a liver transplant recipient. Wien Klin Wochenschr (2007) 1.04
The International Registry on Hand and Composite Tissue Transplantation. Transplantation (2005) 1.03
Nocardiosis following solid organ transplantation: a single-centre experience. Transpl Int (2005) 1.03
SFRP2 methylation in fecal DNA--a marker for colorectal polyps. Int J Colorectal Dis (2007) 1.02
Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients. Transplantation (2004) 1.01
Early detection of emerging forest disease using dispersal estimation and ecological niche modeling. Ecol Appl (2008) 1.00
IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival. J Immunol (2011) 1.00